Doctor Katrin Kemp Gudmundsdottir
Landspitali University Hospital, Reykjavik (Iceland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Using NT-proBNP to screen patients with afib: results from the STROKESTOP II trial.
Event: ESC Congress 2021 - The Digital Experience
Topic: Biomarkers
Session: Cardiac biomarkers are here to stay
NT-proBNP: a valuable marker to screen for Atrial Fibrillation.
Event: ESC Congress 2021 - The Digital Experience
Topic: Arrhythmias, General
Session: Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients
NT-proBNP: a valuable marker to screen for Atrial Fibrillation.
Event: ESC Congress 2021 - The Digital Experience
Topic: Arrhythmias, General
Session: Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients
Pulse palpation and history of palpitations in atrial fibrillation screening - preliminary results from the strokestop 2 study
Event: ESC Congress 2018
Topic: Diagnostic Methods
Session: Atrial fibrillation - Stroke prevention
Mass screening for atrial fibrillation using n-terminal pro b-type natriuretic peptide - preliminary results from the strokestop 2 study
Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Atrial fibrillation - Detection, treatment, outcomes
ESC 365 is supported by
